Role of Vitamin K-dependent Carboxylation in Glucose-Stimulated Insulin Secretion and Calcium Regulation in β Cells

Jaya Shree^*
*Correspondence: Jaya Shree, Department of Human Nutrition, Tufts University, Boston, USA, Email:

Introduction

Vitamin K, well-known for its role in blood clotting, is now emerging as a key player in regulating Glucose-Stimulated Insulin Secretion and calcium homeostasis in pancreatic β cells. Specifically, we delve into the role of the γ-carboxylated protein ERGP in controlling store-operated calcium entry and shed light on the intricate mechanisms underlying these processes. Vitamin K-dependent carboxylation, mediated by the enzyme γ-glutamyl carboxylase, is crucial for the activation of specific proteins involved in various physiological processes. Recent studies have unveiled the role of vitamin K-dependent carboxylation in modulating GSIS in pancreatic β cells. It has been discovered that the presence of γ-carboxylated proteins influences the efficiency of insulin secretion in response to glucose stimulation.

Description

The intricate interplay between vitamin K-dependent carboxylation and GSIS provides a novel avenue for understanding and potentially modulating insulin secretion in diabetes and related metabolic disorders. One such γ-carboxylated protein, Endoplasmic Reticulum Gamma-carboxyglutamic Acid Protein, has emerged as a critical regulator of SOCE in pancreatic β cells. SOCE is a vital mechanism for calcium entry into the cytoplasm, essential for the subsequent steps leading to insulin secretion. ERGP acts as a modulator of the key SOCE components, STIM1 and Orai1, controlling their assembly into puncta structures and thereby regulating calcium influx. The precise γ-carboxylation of ERGP appears to play a pivotal role in fine-tuning SOCE and maintaining calcium homeostasis in β cells [1].

Studies have demonstrated that γ-carboxylation of ERGP influences the assembly and dynamics of STIM1 and Orai1 puncta, which are essential for efficient calcium signaling. Specifically, ERGP γ-carboxylation has been found to reduce STIM1 and Orai1 puncta formation, potentially modulating calcium entry into the β cells. This regulatory mechanism adds a layer of complexity to the finely tuned calcium signaling machinery in pancreatic β cells. Interestingly, the decarboxylation of ERGP, resulting in the absence of γ-carboxyglutamic acid residues, has been linked to disrupted calcium homeostasis and aberrant insulin secretion [2].

Decarboxylated ERGP has been shown to cause calcium overfilling in β cells, leading to sustained calcium elevation and subsequent hyperinsulinemia. These findings highlight the significance of γ-carboxylation in maintaining calcium balance and normal insulin secretion, while underscoring the potential implications of ERGP decarboxylation in β cell dysfunction. The intricate relationship between vitamin K-dependent carboxylation and glucose-stimulated insulin secretion is becoming increasingly evident. The γ-carboxylated protein ERGP has emerged as a key player in controlling store-operated calcium entry, thereby modulating calcium signaling and insulin secretion in pancreatic β cells. Understanding the mechanisms underlying vitamin K-dependent carboxylation and its impact on ERGP function provides valuable insights into the regulation of β cell physiology. Further research in this field holds promise for novel therapeutic approaches targeting vitamin K-dependent carboxylation and its associated pathways to optimize insulin secretion and potentially address dysregulated glucose metabolism in diabetes and related disorders [3].

Calcium signaling plays a crucial role in pancreatic β cells, governing insulin secretion in response to glucose stimulation. Emerging evidence suggests that the γ-carboxylation of Endoplasmic Reticulum Gamma-carboxyglutamic Acid Protein plays a critical role in modulating calcium signaling and insulin secretion. This article explores the intriguing relationship between ERGP γ-carboxylation, STIM1 and Orai1 puncta formation and the consequences of decarboxylated ERGP on calcium homeostasis and hyperinsulinemia in β cells. The γ-carboxylation of ERGP, catalyzed by γ-glutamyl carboxylase, emerges as a crucial factor in regulating the assembly and dynamics of STIM1 and Orai1 puncta structures [4].

STIM1 acts as a calcium sensor in the endoplasmic reticulum while Orai1 is responsible for calcium influx from the extracellular space. ERGP γ-carboxylation has been found to reduce STIM1 and Orai1 puncta formation, thereby influencing the efficiency of calcium entry into the cytoplasm. This regulatory mechanism underscores the significance of ERGP γ-carboxylation in fine-tuning calcium signaling in β cells. In contrast, the decarboxylation of ERGP, resulting in the absence of γ-carboxyglutamic acid residues, has been associated with dysregulated calcium homeostasis and hyperinsulinemia. Decarboxylated ERGP disrupts calcium balance in β cells, leading to calcium overfilling within the cytoplasm.

The sustained elevation of intracellular calcium triggers excessive insulin secretion, contributing to hyperinsulinemia. These findings highlight the critical role of ERGP γ-carboxylation in maintaining calcium homeostasis and preventing excessive insulin release. The exact mechanisms by which decarboxylated ERGP leads to calcium overfilling in β cells are not yet fully elucidated. However, it is hypothesized that the absence of γ-carboxyglutamic acid residues alters the interaction between ERGP and calcium-regulating proteins, impacting calcium buffering capacity and intracellular calcium dynamics. Disrupted calcium handling and sustained calcium elevation may trigger various downstream signaling pathways, ultimately leading to hyperinsulinemia [5].

Conclusion

The dysregulation of ERGP γ-carboxylation and subsequent calcium signaling in β cells has significant implications for diabetes and related metabolic disorders. Understanding the precise mechanisms involved in ERGP-mediated regulation of STIM1, Orai1 and calcium dynamics may provide valuable insights into the pathogenesis of insulin dysregulation and hyperinsulinemia. Furthermore, targeting ERGP γ-carboxylation and calcium signaling pathways may offer novel therapeutic strategies to restore normal insulin secretion and glucose homeostasis in diabetes. ERGP γ-carboxylation emerges as a critical determinant of calcium signaling and insulin secretion in pancreatic β cells. The modulation of STIM1 and Orai1 puncta formation by γ-carboxylated ERGP highlights its role in regulating calcium entry and subsequent insulin release. Conversely, decarboxylated ERGP disrupts calcium homeostasis, leading to calcium overfilling and hyperinsulinemia. Understanding the intricacies of ERGP γ-carboxylation and its impact on calcium dynamics provides new avenues for therapeutic interventions aimed at optimizing insulin secretion and addressing dysregulated glucose metabolism in diabetes and related conditions.

References

1. Lacombe, Julie, Kevin Guo, Jessica Bonneau and Denis Faubert, et al. "Vitamin K-dependent carboxylation regulates Ca2+ flux and adaptation to metabolic stress in β cells." Cell Rep 42 (2023).

Google Scholar, Crossref, Indexed at

2. Shao, Jin, Zhi Wang, Tieyi Yang and Hui Ying, et al. "Bone regulates glucose metabolism as an endocrine organ through osteocalcin." Int J Endocrinol 2015 (2015).

Google Scholar, Crossref, Indexed at

3. Ho, Hsin-Jung, Michio Komai and Hitoshi Shirakawa. "Beneficial effects of vitamin K status on glycemic regulation and diabetes mellitus: A mini-review." Nutrients 12 (2020): 2485.

Google Scholar, Crossref, Indexed at

4. Stępień, Anna, Małgorzata Koziarska-Rościszewska, Jacek Rysz and Mariusz Stępień. "Biological role of vitamin K—with particular emphasis on cardiovascular and renal aspects." Nutrients 14 (2022): 262.

Google Scholar, Crossref, Indexed at

5. Li, Yan, Jie peng Chen, Lili Duan and Shuzhuang Li. "Effect of vitamin K2 on type 2 diabetes mellitus: A review." Diabetes Res Clin Pract 136 (2018): 39-51.

Google Scholar, Crossref, Indexed at